Glossary
Pharma Omnichannel terms, defined for practitioners
Short definitions of the terms used in our work and on this site, written for Commercial, Medical and Digital teams. Each definition says what the term means in practice and where it is often misunderstood.
- Omnichannel
- A way of planning and running HCP engagement so that field, remote and digital interactions are coordinated around what each HCP needs, rather than run as separate channel programs. In pharma the term is often used for any multichannel activity. The difference is coordination and a shared view of the customer.
- Multichannel
- Engagement through several channels that are planned and measured separately. Most pharma companies are multichannel in practice even when they describe their model as Omnichannel.
- Optichannel
- An emphasis within Omnichannel on choosing the few channels, messages and moments that serve a given HCP best, and leaving out the rest. It is a change of priority rather than a new discipline. Fewer, better-timed interactions replace broad coverage.
- Customer engagement journey
- The sequence of interactions an HCP has with a company over time, across channels and teams, seen from the HCP's side. Journey design decides what the HCP should experience at each stage and which team is responsible for it.
- HCP persona
- A description of a group of HCPs who share needs, preferences and ways of working, used to plan content and channels. A persona is useful when it changes a plan. A persona that describes demographics only rarely does.
- Channel affinity
- A measure of how far an individual HCP or a group responds to and prefers a particular channel. It is observed from behavior over time, and it changes. Affinity data is often confused with reach data, which only shows that a channel was used.
- Channel mix
- The combination of field, remote and digital channels planned for a brand, a segment or an HCP, and how effort is split between them. The mix is a planning decision, and it should follow affinity, cost and the role each channel plays in the journey.
- Next Best Action
- A decision support capability that uses data about each HCP to suggest what should happen next, such as a visit, a piece of content or no contact. The suggestion can go to a representative, a marketing team or an automated channel. The value depends on whether people act on it.
- Engagement signal
- An observed change in HCP behavior, such as opening content, attending an event or asking a question, that indicates interest or a need. Signals feed Next Best Action and journey orchestration. A signal is only useful when it is recent, trusted and tied to a possible action.
- Orchestration
- The rules and routines that decide which interaction follows which, across channels and teams, so that an HCP's experience holds together. Orchestration can be manual, rule-based or supported by AI. Whatever the mechanism, somebody has to own the rules.
- Editorial calendar
- A shared plan of what content goes to which audience, through which channel and when, across a brand or a portfolio. It turns a strategy into a sequence that field, marketing and medical teams can see and act on together.
- Modular content
- Content built as approved, reusable components that can be assembled into different formats and channels, rather than as single finished assets. It speeds up review and localization when the governance for assembly is in place.
- Content tagging
- Descriptive labels attached to each piece of content, such as topic, audience, journey stage and format, that let systems and people find and sequence it. Without consistent tagging, orchestration and Next Best Action have little to choose from.
- HCP consent
- The recorded permission from an HCP to be contacted through a given channel for a given purpose. Consent is specific to purpose and channel, and it must be visible to every system that acts on it. An opt-out in one channel should reach all of them.
- Channel preference
- What an HCP says about how they wish to be engaged, as distinct from channel affinity, which is what their behavior shows. Both matter, and they often differ.
- Reach and frequency
- Reach is the share of a target audience that received at least one interaction in a period. Frequency is how many interactions each reached HCP received. Both describe activity, and neither shows whether the activity was useful.
- Engagement rate
- The share of delivered interactions that an HCP responded to, such as content opened or a session attended. It is a leading indicator of interest. It should be read by channel and by audience, since averages hide most of the information.
- Leading KPI
- A measure that moves early and indicates whether an engagement plan is working, such as the share of priority HCPs reached through more than one channel. Leading KPIs let teams correct course within a planning cycle.
- Lagging KPI
- A business result that arrives after the engagement that influenced it, such as prescriptions, market share or revenue. Lagging KPIs confirm impact. They are too slow on their own to guide execution.
- Attribution
- The assignment of a business result to the interactions that contributed to it. Full attribution at HCP level is rarely possible in pharma, because of data limits and privacy. Useful measurement usually relies on comparison and trend evidence instead.
- Incrementality
- The difference in results between HCPs or markets that received a particular engagement and comparable ones that did not. It is the most credible way to show that engagement changed something, and it needs a comparison group planned in advance.
- Omnichannel ROI
- The relationship between what engagement cost, across field, digital, agency and internal time, and the business result it influenced. It is best shown through a small number of credible examples with a baseline, rather than a single site-wide figure.
- Omnichannel maturity
- A description of how far an organization's data, content, processes, people and governance support coordinated engagement. Maturity is a position to act from. Maturity scores are useful when they lead to a decision and misleading when they become the goal.
- Hybrid representative
- A field role that combines in-person visits with remote and digital interactions, planned together for the same HCPs. The role changes what representatives are measured on, which is why it needs new coaching and incentives, as well as new tools.
- Medical science liaison
- A field-based Medical Affairs professional who exchanges scientific information with HCPs and captures insight for the company. In an Omnichannel model the liaison is one channel among several, and often the most valued one.
- Scientific exchange
- The non-promotional sharing of scientific and medical information between a company's Medical function and HCPs. It follows its own rules on content, initiation and records, and it must stay separate from promotional activity in every channel.
- Medical, legal and regulatory review
- The process by which content and, increasingly, engagement journeys are reviewed for accuracy, balance and compliance before use. Involving reviewers at the planning stage shortens review and reduces late changes.
- Omnichannel operating model
- The way an organization arranges roles, decisions, processes, data and technology so that coordinated engagement happens as normal work, rather than as a project. Most Omnichannel programs stall at the point where the operating model has not changed.
- Global-to-local
- The way a global strategy, playbook or content set is adapted and run in affiliates. The usual failure is a global plan that assumes affiliate capabilities, data and HCP expectations that do not exist locally.
- Adoption
- The extent to which people change how they work because of a new capability, such as a Next Best Action tool or a journey plan. Adoption is the point where most Omnichannel value is won or lost, and it is an organizational question before it is a technical one.
Go deeper
Where these terms are used
The Insights articles show the terms in context, and the free guides turn them into questions your team can answer.
Let's talk about your next planning cycle
Book a complimentary 45-minute working session. Bring the question that matters most to your team and leave with a recommended first step.
Last updated 6 November 2026